Activation of hypoxia-inducible factor 1 in human T-cell leukaemia virus type 1-infected cell lines and primary adult T-cell leukaemia cells

Biochemical Journal

Volumn 406, Issue 2, 2007, Pages 317-323

  Tomita, Mariko ^a   Semenza, Gregg L ^b   Michiels, Canine ^c   Matsuda, Takehiro ^a   Uchihara, Jun Nosuke ^a   Okudaira, Taeko ^a   Tanaka, Yuetsu ^a   Taira, Naoya ^d   Ohshiro, Kazuiku ^e   Mori, Naoki ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NAMUR   (Belgium)

^d Heart Life Hospital   (Japan)

^e Children's Medical Center   (Japan)

Author keywords

Adult t cell leukaemia (ATL); Akt; Human T cell leukaemia virus type 1 (HTLV 1); Hypoxia inducible factor 1 (HIF 1); Phosphoinositide 3 kinase (PI3K); Tax

Indexed keywords

CELLS; ONCOLOGY; PATIENT TREATMENT; PROTEINS; TRANSCRIPTION; TUMORS;

ADULT T-CELL LEUKAEMIA (ATL); HUMAN T-CELL LEUKAEMIA VIRUS TYPE 1 (HTLV-1); HYPOXIA-INDUCIBLE FACTOR 1 (HIF-1); PHOSPHOINOSITIDE 3-KINASE (PI3K);

VIRUSES;

2 MORPHOLINO 8 PHENYLCHROMONE; HYPOXIA INDUCIBLE FACTOR 1; PROTEIN KINASE B; SMALL INTERFERING RNA; VASCULOTROPIN;

ARTICLE; BINDING AFFINITY; CELL ACTIVATION; DNA BINDING; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS; LEUKEMIA CELL; OXYGEN CONCENTRATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; T CELL LEUKEMIA; TUMOR GROWTH;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADULT; DNA; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE PRODUCTS, TAX; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LEUKEMIA, T-CELL; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 34548176273     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20070286     Document Type: Article

References (50)

1. Poiesz, B. J., Ruscetti, F. W., Gazdar, A. F., Bunn, P. A., Minna, J. D. and Gallo, R. C. (1980) Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. U.S.A. 77, 7415-7419
2. Hinuma, Y., Nagata, K., Hanaoka, M., Nakai, M., Matsumoto, T., Kinoshita, K. I., Shirakawa, S. and Miyoshi, I. (1981) Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc. Natl. Acad. Sci. U.S.A. 78, 6476-6480
3. Yoshida, M., Miyoshi, I. and Hinuma, Y. (1982) Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc. Natl. Acad. Sci. U.S.A. 79, 2031-2035
4. Tajima, K. (1990) The 4th nation-wide study of adult T-cell leukemia/lymphoma (ATL) in Japan: estimates of risk of ATL and its geographical and clinical features. The T- and B-cell Malignancy Study Group. Int. J. Cancer. 45, 237-243
5. Yamada, Y., Tomonaga, M., Fukuda, H., Hanada, S., Utsunomiya, A., Tara, M., Sano, M., Ikeda, S., Takatsuki, K., Kozuru, M. et al. (2001) A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303. Br. J. Haematol. 113, 375-382
6. Siegel, R. S., Gartenhaus, R. B. and Kuzel, T. M. (2001) Human T-cell lymphotropic-I-associated leukemia/lymphoma. Curr. Treat. Options Oncol. 2, 291-300
7. Grassmann, R., Berchtold, S., Radant, I., Alt, M., Fleckenstein, B., Sodroski, J. G., Haseltine, W. A. and Ramstedt, U. (1992) Role of human T-cell leukemia virus type 1 X region proteins in immortalization of primary human lymphocytes in culture. J. Virol. 66, 4570-4575
8. Grassmann, R., Dengler, C., Muller-Fleckenstein, I., Fleckenstein, B., McGuire, K., Dokhelar, M. C., Sodroski, J. G. and Haseltine, W. A. (1989) Transformation to continuous growth of primary human T lymphocytes by human T-cell leukemia virus type I X-region genes transduced by a Herpes virus saimiri vector. Proc. Natl. Acad. Sci. U.S.A. 86, 3351-3355
9. Nerenberg, M., Hinrichs, S. H., Reynolds, R. K., Khoury, G. and Jay, G. (1987) The tat gene of human T-lymphotropic virus type 1 induces mesenchymal tumors in transgenic mice. Science 237, 1324-1329
10. Hasegawa, H., Sawa, H., Lewis, M. J., Orba, Y., Sheehy, N., Yamamoto, Y., Ichinohe, T., Tsunetsugu-Yokota, Y., Katano, H., Takahashi, H. et al. (2006) Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I. Nat. Med. 12, 466-472
11. Grassmann, R., Aboud, M. and Jeang, K. T. (2005) Molecular mechanisms of cellular transformation by HTLV-1 Tax. Oncogene 24, 5976-5985
12. Semenza, G. L. and Wang, G. L. (1992) A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site reguired for transcriptional activation. Mol. Cell. Biol. 12, 5447-5454
13. Semenza, G. L. (2003) Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer. 3, 721-732
14. 2 tension. Proc. Natl. Acad. Sci. U.S.A. 92, 5510-5514
15. Aebersold, D. M., Burri, P., Beer, K. T., Laissue, J., Djonov, V., Greiner, R. H. and Semenza, G. L. (2001) Expression of hypoxia-inducible factor-1α: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res. 61, 2911-2916
16. Birner, P., Schindl, M., Obermair, A., Breitenecker, G. and Oberhuber, G. (2001) Expression of hypoxia-inducible factor 1α in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy. Clin. Cancer Res. 7, 1661-1668
17. Zundel, W., Schindler, C., Haas-Kogan, D., Koong, A., Kaper, F., Chen, E., Gottschalk, A. R., Ryan, H. E., Johnson, R. S., Jefferson, A. B. et al. (2000) Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev. 14, 391-396
18. Ravi, R., Mookerjee, B., Bhujwalla, Z. M., Sutter, C. H., Artemov, D., Zeng, Q., Dillehay, L. E., Madan, A., Semenza, G. L. and Bedi, A. (2000) Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α. Genes Dev. 14, 34-44
19. Maxwell, P. H., Wiesener, M. S., Chang, G. W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. B. and Ratcliffe, P. J. (1999) The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399, 271-275
20. Kami, R., Dor, Y., Keshet, E., Meyuhas, O. and Levitzki, A. (2002) Activated pp60c-Src leads to elevated hypoxia-inducible factor (HIF)-1α expression under normoxia. J. Biol. Chem. 277, 42919-42925
21. Zhong, H., Chiles, K., Feldser, D., Laughner, E., Hanrahan, C., Georgescu, M. M., Simons, J. W. and Semenza, G. L. (2000) Modulation of hypoxia-inducible factor 1α expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res. 60, 1541-1545
22. Mazure, N. M., Chen, E. Y., Laderoute, K. B. and Giaccia, A. J. (1997) Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element. Blood 90, 3322-3331
23. Laughner, E., Taghavi, P., Chiles, K., Mahon, P. C. and Semenza, G. L. (2001) HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1α (HIF-1α) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol. Cell. Biol. 21, 3995-4004
24. Arsham, A. M., Plas, D. R., Thompson, C. B. and Simon, M. C. (2002) Phosphatidylinositol 3-kinase/Akt signaling is neither required for hypoxic stabilization of HIF-1α nor sufficient for HIF-1-dependent target gene transcription. J. Biol. Chem. 277, 15162-15170
25. Tomita, M., Kikuchi, A., Akiyama, T., Tanaka, Y. and Mori, N. (2006) Human T-cell leukemia virus type 1 tax dysregulates β-catenin signaling. J. Virol. 80, 10497-10505
26. Tomita, M., Matsuda, T., Kawakami, H., Uchihara, J. N., Okudaira, T., Masuda, M., Ohshiro, K. and Mori, N. (2006) Curcumin targets Akt cell survival signaling pathway in HTLV-I-infected T-cell lines. Cancer Sci. 97, 322-327
27. Liu, Y., Wang, Y., Yamakuchi, M., Masuda, S., Tokioka, T., Yamaoka, S., Maruyama, I. and Kitajima, I. (2001) Phosphoinositide-3 kinase-PKB/Akt pathway activation is involved in fibroblast Rat-1 transformation by human T-cell leukemia virus type I tax. Oncogene 20, 2514-2526
28. Jeong, S. J., Pise-Masison, C. A., Radonovich, M. F., Park, H. U. and Brady, J. N. (2005) Activated AKT regulates NF-κB activation, p53 inhibition and cell survival in HTLV-1-transformed cells. Oncogene 24, 6719-6728
29. Peloponese, Jr, J. M. and Jeang, K. T. (2006) Role for Akt/protein kinase B and activator protein-1 in cellular proliferation induced by the human T-cell leukemia virus type 1 tax oncoprotein. J. Biol. Chem. 281, 8927-8938
30. Ikezoe, T., Nishioka, C., Bandobashi, K., Yang, Y., Kuwayama, Y., Adachi, Y., Takeuchi, T., Koeffler, H. P. and Taguchi, H. (2007) Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells. Leuk. Res. 31, 673-682
31. Miyoshi, I., Kubonishi, I., Yoshimoto, S., Akagi, T., Ohtsuki, Y., Shiraishi, Y., Nagata, K. and Hinuma, Y. (1981) Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature 294, 770-771
32. Yamamoto, N., Okada, M., Koyanagi, Y., Kannagi, M. and Hinuma, Y. (1982) Transformation of human leukocytes by cocultivation with an adult T cell leukemia virus producer cell line. Science 217, 737-739
33. Koeffler, H. P., Chen, I. S. and Golde, D. W. (1984) Characterization of a novel HTLV-infected cell line. Blood 64, 482-490
34. Tomita, M., Choe, J., Tsukazaki, T. and Mori, N. (2004) The Kaposi's sarcoma-associated herpesvirus K-bZIP protein represses transforming growth factor β signaling through interaction with CREB-binding protein. Oncogene 23, 8272-8281
35. Tanaka, Y., Yoshida, A., Takayama, Y., Tsujimoto, H., Tsujimoto, A., Hayami, M. and Tozawa, H. (1990) Heterogeneity of antigen molecules recognized by anti-taxi monoclonal antibody Lt-4 in cell lines bearing human T cell leukemia virus type I and related retroviruses. Jpn. J. Cancer Bes. 81, 225-231
36. Mori, N., Fujii, M., Iwai, K., Ikeda, S., Yamasaki, Y., Hata, T., Yamada, Y., Tanaka, Y., Tomonaga, M. and Yamamoto, N. (2000) Constitutive activation of transcription factor AP-1 in primary adult T- cell leukemia cells. Blood 95, 3915-3921
37. Jiang, B. H., Rue, E., Wang, G. L., Roe, R. and Semenza, G. L. (1996) Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J. Biol. Chem. 271, 17771-17778
38. Michel, G., Minet, E., Mottet, D., Remade, J. and Michiels, C. (2002) Site-directed mutagenesis studies of the hypoxia-inducible factor-1α DNA-binding domain. Biochim. Biophys. Acta 1578, 73-83
39. Harrod, R., Tang, Y., Nicot, C., Lu, H. S., Vassilev, A., Nakatani, Y. and Giam, C. Z. (1998) An exposed KID-like domain in human T-cell lymphotropic virus type 1 Tax is responsible for the recruitment of coactivators CBP/p300. Mol. Cell. Biol. 18, 5052-5061
40. Matsumoto, K., Shibata, H., Fujisawa, J. I., Inoue, H., Hakura, A., Tsukahara, T. and Fujii, M. (1997) Human T-cell leukemia virus type 1 Tax protein transforms rat fibroblasts via two distinct pathways. J. Virol. 71, 4445-4451
41. Takeuchi, K., Kobayashi, N., Nam, S. H., Yamamoto, N. and Hatanaka, M. (1985) Molecular cloning of cDNA encoding gp68 of adult T-cell leukaemia-associated antigen: evidence for expression of the pX IV region of human T-cell leukaemia virus. J. Gen. Virol. 66, 1825-1829
42. Bjornsti, M. A. and Houghton, P. J. (2004) Lost in translation: dysregulation of cap-dependent translation and cancer. Cancer Cell. 5, 519-523
43. Fukuda, R., Hayashi, A., Utsunomiya, A., Nukada, Y., Fukui, R., Itoh, K., Tezuka, K., Ohashi, K., Mizuno, K., Sakamoto, M. et al. (2005) Alteration of phosphatidylinositol 3-kinase cascade in the multilobulated nuclear formation of adult T cell leukemia/lymphoma (ATLL). Proc. Natl. Acad. Sci. U.S.A. 102, 15213-15218
44. Kondo, S., Seo, S. Y., Yoshizaki, T., Wakisaka, N., Furukawa, M., Joab, I., Jang, K. L. and Pagano, J. S. (2006) EBV latent membrane protein 1 up-regulates hypoxia-inducible factor 1α through Siah1-mediated down-regulation of prolyl hydroxylases 1 and 3 in nasopharyngeal epithelial cells. Cancer Res. 66, 9870-9877
45. Moon, E. J., Jeong, C. H., Jeong, J. W., Kim, K. R., Yu, D. Y., Murakami, S., Kim, C. W. and Kim, K. W. (2004) Hepatitis B virus X protein induces angiogenesis by stabilizing hypoxia-inducible factor-1α. FASEB J. 18, 382-384
46. Sodhi, A., Montaner, S., Patel, V., Zohar, M., Bais, C., Mesri, E. A. and Gutkind, J. S. (2000) The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1α. Cancer Res. 60, 4873-4880
47. Harris, A. L. (2002) Hypoxia: a key regulatory factor in tumour growth. Nat. Rev. Cancer 2, 38-47
48. Liao, D., Corle, C., Seagroves, T. N. and Johnson, R. S. (2007) Hypoxia-inducible factor-1α is a key regulator of metastasis in a transgenic model of cancer initiation and progression. Cancer Res. 67, 563-572
49. Park, E. J., Kong, D., Fisher, R., Cardellina, J., Shoemaker, R. H. and Melillo, G. (2006) Targeting the PAS-A domain of HIF-1α for development of small molecule inhibitors of HIF-1. Cell Cycle 5, 1847-1853
50. Yamazaki, Y., Hasebe, Y., Egawa, K., Nose, K., Kunimoto, S. and Ikeda, D. (2006) Anthracyclines, small-molecule inhibitors of hypoxia-inducible factor-1α activation. Biol. Pharm. Bull. 29, 1999-2003